deferiprone has been researched along with Anemia, Aplastic in 5 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
Anemia, Aplastic: A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Weekly monitoring of absolute neutrophil count (ANC) under deferiprone therapy in thalassemia patients is recommended to avoid agranulocytosis adverse event." | 7.83 | Frequency of neutropenia among Turkish and Syrian pediatric thalassemia patients under deferiprone monotherapy. ( Belen, BF; Özsevik, SN; Polat, M; Soylu, E, 2016) |
| "Weekly monitoring of absolute neutrophil count (ANC) under deferiprone therapy in thalassemia patients is recommended to avoid agranulocytosis adverse event." | 3.83 | Frequency of neutropenia among Turkish and Syrian pediatric thalassemia patients under deferiprone monotherapy. ( Belen, BF; Özsevik, SN; Polat, M; Soylu, E, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jang, JH | 1 |
| Lee, JH | 1 |
| Yoon, SS | 1 |
| Jo, DY | 1 |
| Kim, HJ | 1 |
| Chung, J | 1 |
| Lee, JW | 1 |
| Nijjar, PS | 1 |
| Vongooru, H | 1 |
| Tamene, A | 1 |
| Valeti, U | 1 |
| Masri, C | 1 |
| Belen, BF | 1 |
| Polat, M | 1 |
| Özsevik, SN | 1 |
| Soylu, E | 1 |
| Olivieri, NF | 1 |
| Koren, G | 1 |
| Hermann, C | 1 |
| Bentur, Y | 1 |
| Chung, D | 1 |
| Klein, J | 1 |
| St Louis, P | 1 |
| Freedman, MH | 1 |
| McClelland, RA | 1 |
| Templeton, DM | 1 |
| Hoffbrand, AV | 1 |
| Bartlett, AN | 1 |
| Veys, PA | 1 |
| O'Connor, NT | 1 |
| Kontoghiorghes, GJ | 1 |
1 trial available for deferiprone and Anemia, Aplastic
| Article | Year |
|---|---|
Comparison of oral iron chelator L1 and desferrioxamine in iron-loaded patients.
Topics: Adolescent; Adult; Anemia, Aplastic; Animals; Blood Transfusion; Child; Cohort Studies; Combined Mod | 1990 |
4 other studies available for deferiprone and Anemia, Aplastic
| Article | Year |
|---|---|
Korean guideline for iron chelation therapy in transfusion-induced iron overload.
Topics: Anemia, Aplastic; Benzoates; Chelation Therapy; Deferasirox; Deferiprone; Humans; Iron Chelating Age | 2013 |
Improvement in Left Ventricular Function Despite No Change in T2* with Iron Chelation in Secondary Hemochromatosis.
Topics: Adult; Anemia, Aplastic; Deferiprone; Deferoxamine; Echocardiography; Hemochromatosis; Humans; Iron | 2015 |
Frequency of neutropenia among Turkish and Syrian pediatric thalassemia patients under deferiprone monotherapy.
Topics: Adolescent; Anemia, Aplastic; Anemia, Hemolytic; Blood Transfusion; Bone Marrow Diseases; Bone Marro | 2016 |
Agranulocytosis and thrombocytopenia in patient with Blackfan-Diamond anaemia during oral chelator trial.
Topics: Adult; Agranulocytosis; Anemia, Aplastic; Deferiprone; Female; Humans; Iron Chelating Agents; Pyrido | 1989 |